http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PA-8462701-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c76ecadad74a1a35270b3e3a34d60f37
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D243-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
filingDate 1998-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c131c45399d8659e827ade08975dd44
publicationDate 2000-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PA-8462701-A1
titleOfInvention REPLACEMENT OF CATECOL INDAZOL BIOISOSTERE IN THERAPEUTICALLY ACTIVE COMPOUNDS
abstract THERAPEUTICALLY ACTIVE MATTER COMPOSITIONS AND TYPES OF MEMBERS OF THE SAME THAT INCLUDE COMPOUNDS CONTAINING INDAZOL, RESULTING FROM SUCH COMPOUNDS AND THEIR THERAPEUTIC ACTIVITY DIRECTLY SUBSTITUTE BY A TEUIU DEUTIOUIUIU NOT CATECOL ARE THE SAME OR APPROVALS BEFORE AND AFTER SUCH SUBSTITUTION, IN WHICH SUCH MATERIAL COMPOSITIONS INCLUDE A COMPOUND OF FÒRMULA (I) OR (I2): OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME, IN WHICH IN A PREFERRED IT IS HYDROGEN, RA IS CYCLLOHEXYL, AND RB IS ETHYL. RA AND RB ARE EACH OF THEM INDIVIDUALLY AND INDEPENDENTLY HYDROGEN OR NON-CATECOL SUBSTITUTES OF SUCH COMPOUNDS THAT ARE PRODUCED DIRECTLY BY A BIOISOSTÉRICA SUBSTITUTE OF CATECOLUES, DUEZUES, AND CATECOL DUEI, WHICH HAS CATECOL DUEI THEY OR HOMOLOGISTS BEFORE AND AFTER SUCH SUBSTITUTION, ON THE CONDITION THAT RA AND RH ARE NOT HYDROGEN AT THE SAME TIME. THE THERAPEUTIC ACTIVITY INVOLVED INCLUDES AN INHIBITING ACTIVITY OF CHOLINESTERASE, AN ANTAGONIST ACTIVITY ALPHA-ADRENERGIC AND AGONIST BETA1-ADRENERGIC, AN INHIBITING ACTIVITY OF THE CALCIUM CHANNEL, AN ANTINEOPLASTIC ACTIVITY OF LABORATORY AND A
priorityDate 1997-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407608385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9221
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155

Total number of triples: 19.